Device Trial Radar · NCT06494436
Microvention AnEurysm & STroke Real-life Data cOllection
Last checked: Nov 20, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Dec 30, 2024
Primary completion
Dec 30, 2029
Study completion Jun 30, 2030
Sponsor
- Lead sponsor
- Microvention-Terumo, Inc.Public (4543.T)
- Sponsor type
- Industry
- First posted
- Jul 10, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The MAESTRO registry is a post-market, single-arm, non-interventional, multicenter registry
Conditions
- Intracranial Aneurysm
- Intracranial Aneurysm, Wide Neck Aneurysm, Large Neck Aneurysm Lesion
- Aneurysmal Subarachnoid Hemorrhage
- Ischemic Stroke
- Acute Ischemic Stroke
Interventions
All Microvention Class III implantable device CE markedDevice
Endovascular treatment of ruptured or unruptured intracranial aneurysms with commercially available MicroVention implant devices.
All Microvention Mechanical Thrombectomy Class III device CE markedDevice
Endovascular treatment of acute ischemic stroke with commercially available MicroVention devices.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1: Proportion of aneurysms with complete occlusionTime frame: 18 (±6) months
- Cohort 2: Proportion of patients achieving final mTICI ≥ 2b revascularizationTime frame: Mechanical trombectomy Procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Álvaro Cunqueiro Hospital - University Hospital Complex of Vigo, Department of Radiology
Vigo, Pontevedra, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.